Deeper focus on patient engagement across the pharma/biotech product lifecycle
[1 November 2022] – Origins Insights, a Resonant Group company, today announced the evolution of its unique service offering to become an exclusively patient focused agency.
“Historically, the significant potential contribution of patients to the pre-clinical and clinical investigation of new therapies has been under-recognised,” said Mark Corbett, Chief Innovation Officer, Resonant Group, who will lead the new offering. “Our evolved suite of services builds on our ability to access deep patient insights at all stages of the drug lifecycle, from clinical development, through market access into commercialisation.”
More “Origins Insights Evolves Into Patient Specialist Agency”